PMD Solutions is one of 38 innovative SMEs across Europe selected from the latest round of Horizon 2020 SME Instrument (Phase 2). The funding will be used to finance innovation activities like demonstration, testing, piloting, scaling up and miniaturisation, in addition to developing a mature business plan for their product. The companies will also benefit from 12 days of business coaching.
PMD Solutions has received regulatory approvals for the sales and marketing of the RespiraSense Continuous Respiratory Monitoring device across the European Union.
This milestone now enables PMD Solutions to establish a wider presence by leveraging European approvals in countries on other continents.
On Sunday 16th it was announced that PMD Solutions was to be a finalist of the IMDA Medical Technology Industry Excellence Emerging Company of the Year 2014.